文献速递临床试验与 GCP基础与转化研究

CBIT联合TMS试验:两阶段随机对照试验研究方案,测试神经调控增强慢性抽动青少年行为疗法的效果

The CBIT + TMS trial: study protocol for a two-phase randomized controlled trial testing neuromodulation to augment behavior therapy for youth with chronic tics.
PubMed 文献 · Trials · 2023-07-03

该两阶段随机对照试验将测试抑制性TMS刺激辅助运动区增强CBIT对12-21岁慢性抽动青少年抽动控制能力的疗效。第一阶段比较1Hz rTMS与cTBS及假刺激(N=60),用预设标准决定是否进入第二阶段并选最优方案;第二阶段在新样本(N=60)中比较最优方案与假刺激并检验神经靶向 engagement 与临床结局的关联。

要点

  • CBIT是抽动障碍一线治疗,但仅对约一半患者有效
  • 试验将抑制性TMS刺激SMA作为CBIT的增强策略
  • 第一阶段比较1Hz rTMS、cTBS与假刺激,用Go/No Go标准决定第二阶段

核心结论

  • 该试验将提供TMS增强CBIT是否具有潜在可行性的信息,并揭示潜在神经与行为变化机制。

研究设计与样本

  • 两阶段、里程碑驱动的早期随机对照试验。
  • 第一阶段直接比较两种rTMS增强策略(1Hz rTMS vs cTBS)与假刺激,N=60名12-21岁慢性抽动青少年。
  • 预设可量化的Go/No Go标准指导是否进入第二阶段及选择最优TMS方案。
  • 第二阶段在新样本N=60中比较最优方案与假刺激,并检验神经靶向 engagement 与临床结局的关联。

主要发现

  • 原文未报告结果。

关键数值与推荐

  • 第一阶段比较1Hz rTMS vs cTBS vs 假刺激(N=60)。
  • 第二阶段比较最优方案 vs 假刺激(新样本N=60)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Comprehensive Behavioral Intervention for Tics (CBIT) is a first-line treatment for tic disorders that aims to improve controllability over tics that an individual finds distressing or impairing. However, it is only effective for approximately half of patients. Supplementary motor area (SMA)-directed neurocircuitry plays a strong role in motor inhibition, and activity in this region is thought to contribute to tic expression. Targeted modulation of SMA using transcranial magnetic stimulation (TMS) may increase CBIT efficacy by improving patients' ability to implement tic controllability behaviors. METHODS: The CBIT + TMS trial is a two-phase, milestone-driven early-stage randomized controlled trial. The trial will test whether augmenting CBIT with inhibitory, non-invasive stimulation of SMA with TMS modifies activity in SMA-mediated circuits and enhances tic controllability in youth ages 12-21 years with chronic tics. Phase 1 will directly compare two rTMS augmentation strategies (1 Hz rTMS vs. cTBS) vs. sham in N = 60 participants. Quantifiable, a priori "Go/No Go Criteria" guide the decision to proceed to phase 2 and the selection of the optimal TMS regimen. Phase 2 will compare the optimal regimen vs. sham and test the link between neural target engagement and clinical outcomes in a new sample of N = 60 participants. DISCUSSION: This clinical trial is one of few to date testing TMS augmentation of therapy in a pediatric sample. The results will provide insight into whether TMS is a potentially viable strategy for enhancing CBIT efficacy and reveal potential neural and behavioral mechanisms of change. TRIAL REGISTRATION: ClinicalTrials.gov NCT04578912 . Registered on October 8, 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Conelea C, Greene DJ, Alexander J, et al. The CBIT + TMS trial: study protocol for a two-phase randomized controlled trial testing neuromodulation to augment behavior therapy for youth with chronic tics. Trials. 2023. PMID: 37400828. doi:10.1186/s13063-023-07455-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。